Trial Outcomes & Findings for Evaluation of a Computerized Opioid Overdose Prevention Program (NCT NCT02040077)

NCT ID: NCT02040077

Last Updated: 2017-11-17

Results Overview

The primary outcome is based on performance in the randomized, controlled trial and is change from baseline on a knowledge test that is administered immediately before and after the intervention. At the time of the study, no validated scales to assess general information regarding overdose in a true/false manner were available. Therefore the study developed a scale for the purpose of measuring knowledge increase. The scale included 51 items, rated as "true", "false", or "I don't know" (to discourage random guessing from resulting in accurate responses accidentally). The answers to all items were included as part of the intervention content so it was possible for every answer to be learned. The scale was summed together as a single measure of number correct responses (range 0-51) with no subscales. Higher values indicated more correct responses.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

75 participants

Primary outcome timeframe

Before the intervention (pre-test) and immediately after the intervention (post-test), an average of 10 minutes.

Results posted on

2017-11-17

Participant Flow

Although the study expected to enroll and randomize 75 participants, an additional participant was randomized into the study - resulting in a final overall sample of 76 randomized participants.

Participant milestones

Participant milestones
Measure
Computer + Questions
Will receive computerized intervention and will be required to periodically answer questions embedded within the program correctly to proceed into the next module.
Computer Only
Will receive computerized intervention with no embedded questions
Pamphlet
Receive a printed version of the same intervention
Overall Study
STARTED
27
24
25
Overall Study
COMPLETED
27
24
25
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Evaluation of a Computerized Opioid Overdose Prevention Program

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Computer + Questions
n=27 Participants
Will receive computerized intervention and will be required to periodically answer questions embedded within the program correctly to proceed into the next module.
Computer Only
n=24 Participants
Will receive computerized intervention with no embedded questions
Pamphlet
n=25 Participants
Receive a printed version of the same intervention
Total
n=76 Participants
Total of all reporting groups
Age, Continuous
40.0 years
STANDARD_DEVIATION 13.1 • n=5 Participants
37.8 years
STANDARD_DEVIATION 10.6 • n=7 Participants
41.9 years
STANDARD_DEVIATION 14.1 • n=5 Participants
39.9 years
STANDARD_DEVIATION 12.6 • n=4 Participants
Sex: Female, Male
Female
12 Participants
n=5 Participants
7 Participants
n=7 Participants
12 Participants
n=5 Participants
31 Participants
n=4 Participants
Sex: Female, Male
Male
15 Participants
n=5 Participants
17 Participants
n=7 Participants
13 Participants
n=5 Participants
45 Participants
n=4 Participants
Region of Enrollment
United States
27 Participants
n=5 Participants
24 Participants
n=7 Participants
25 Participants
n=5 Participants
76 Participants
n=4 Participants

PRIMARY outcome

Timeframe: Before the intervention (pre-test) and immediately after the intervention (post-test), an average of 10 minutes.

The primary outcome is based on performance in the randomized, controlled trial and is change from baseline on a knowledge test that is administered immediately before and after the intervention. At the time of the study, no validated scales to assess general information regarding overdose in a true/false manner were available. Therefore the study developed a scale for the purpose of measuring knowledge increase. The scale included 51 items, rated as "true", "false", or "I don't know" (to discourage random guessing from resulting in accurate responses accidentally). The answers to all items were included as part of the intervention content so it was possible for every answer to be learned. The scale was summed together as a single measure of number correct responses (range 0-51) with no subscales. Higher values indicated more correct responses.

Outcome measures

Outcome measures
Measure
Computer + Mastery
n=27 Participants
Will receive computerized intervention and will be required to periodically answer questions embedded within the program correctly to proceed into the next module.
Computer Only
n=24 Participants
Will receive computerized intervention with no embedded questions.
Pamphlet
n=25 Participants
Receive a printed version of the same intervention
Knowledge Gain
Pre-Test
30.6 units on a scale
Standard Deviation 5.75
30.5 units on a scale
Standard Deviation 5.80
27.56 units on a scale
Standard Deviation 5.94
Knowledge Gain
Post-Test
40.7 units on a scale
Standard Deviation 6.22
40.5 units on a scale
Standard Deviation 6.16
36.2 units on a scale
Standard Deviation 10.88

SECONDARY outcome

Timeframe: Immediately after the intervention (an average of 10 minutes).

Participant willingness (yes or no) to recommend the intervention to a family member or friend.

Outcome measures

Outcome measures
Measure
Computer + Mastery
n=27 Participants
Will receive computerized intervention and will be required to periodically answer questions embedded within the program correctly to proceed into the next module.
Computer Only
n=24 Participants
Will receive computerized intervention with no embedded questions.
Pamphlet
n=25 Participants
Receive a printed version of the same intervention
Percent Participants Who Would Recommend the Intervention to a Family Member or Friend.
27 Participants
24 Participants
25 Participants

Adverse Events

Computer + Mastery

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Computer Only

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Pamphlet

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Kelly Dunn

Johns Hopkins University School of Medicine

Phone: 410-550-2254

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place